Filter
924
Filtered Results: 924
Text search:
pharmaceutical
regulatory
authority
Featured
Recommendations
77
New Publications
285
Language
Document type
No document type
478
Studies & Reports
167
Guidelines
137
Manuals
56
Strategic & Response Plan
51
Fact sheets
14
Training Material
9
Situation Updates
8
Resource Platforms
3
Brochures
1
Countries / Regions
Kenya
41
Ethiopia
39
India
32
Uganda
27
South Africa
23
Global
22
Liberia
21
Nigeria
19
Ghana
19
Rwanda
18
Tanzania
17
Sierra Leone
16
Zambia
16
Bangladesh
15
Malawi
15
Nepal
14
Namibia
13
Western and Central Europe
13
Zimbabwe
10
Ukraine
10
Syria
9
Cambodia
9
Myanmar / Burma
9
Philippines
8
Lesotho
8
Botswana
7
Africa
7
Eastern Europe
7
South–East Asia Region
6
Indonesia
5
Eswatini/ Swaziland
5
West and Central Africa
5
Congo, Democratic Republic of
4
East and Southern Africa
4
Western Pacific Region
4
Latin America and the Carribbean
4
Guinea
3
Burkina Faso
3
Pakistan
3
Jordan
3
Thailand
3
Benin
3
Middle East and North Africa
3
Eastern Europe and Central Asia
3
Albania
3
Senegal
2
USA
2
Cameroon
2
Haiti
2
Mozambique
2
Asia
2
Laos
2
Mali
1
Somalia
1
Iraq
1
Afghanistan
1
Germany
1
Lebanon
1
Egypt
1
Chad
1
Papua New Guinea
1
Sudan
1
Central African Republic
1
North Macedonia
1
Madagascar
1
Fiji
1
Timor Leste/ East Timor
1
Russia
1
Moldova
1
Iran
1
Australia
1
Vietnam
1
Gabon
1
Turkmenistan
1
Denmark
1
Maldives
1
United Kingdom
1
Authors & Publishers
Publication Years
Category
Countries
413
Clinical Guidelines
57
Public Health
36
Key Resources
29
Pharmacy & Technologies
27
Women & Child Health
23
Capacity Building
4
Toolboxes
AMR
120
Pharmacy
117
COVID-19
53
HIV
38
TB
38
Rapid Response
34
Mental Health
32
Global Health Education
20
Planetary Health
19
Conflict
14
Caregiver
14
Ebola
13
Specific Hazards
10
NCDs
10
NTDs
9
Health Financing Toolbox
9
Polio
5
Disability
2
Natural Hazards
2
Refugee
2
Zika
2
Social Ethics
1
This report’s central premise is that diagnostics and therapeutics, and associated test to treat strategies, are fundamental components of the pandemic response, both for COVID-19 and for future health threats. Two years into the COVID-19 pandemic, this report reflects on the main challenges and k...
These guidelines provide updated evidence-based recommendations on the priority HCV-related topics from the 2018 WHO Guidelines for the care and treatment of persons diagnosed with chronic hepatitis C infection and the 2017 WHO Guidelines on hepatitis B and C testing. These priority areas are:
...
The World Health Organization (WHO) and the global community of countries, partners, donors, technical experts, scientists and field implementation teams continue to work towards the ultimate goal of a world free of the burden of neglected tropical diseases (NTDs).
This report includes analysis from informal regional consultations in the African Region, the Caribbean and North America, Latin America, South-East Asia Region, European Region, Eastern Mediterranean Region, alongside three forums in the Western Pacific Region. It analyses the overarching similarit...
The Mapping Antimicrobial Resistance and Antimicrobial Use Partnership (MAAP) project has conducted a multi-year, multi-country study that provides stark insights on the under-reported depth of the antimicrobial resistance (AMR) crisis across Africa and lays out urgent policy recommendations to addr...
This document lays out economic arguments for investing in the Access to COVID-19 Tools Accelerator (ACT-Accelerator). Framed within an overall context that recognizes the broader human health and societal impacts of the COVID-19 crisis, ACT-Accelerator's Economic Investment Case argues that investm...
This report includes analysis from informal regional consultations in the African Region, the Caribbean and North America, Latin America, South-East Asia Region, European Region, Eastern Mediterranean Region, alongside three forums in the Western Pacific Region. It analyses the overarching similarit...
WHO’s Country Cooperation Strategy (CCS) defines the Organization’s medium-term vision for working in and with a particular country. The CCS, developed in the context of global and national health priorities, examines the overall health situation in a country, including the state of the health s...
Transforming Health: Accelerating attainment of Health Goals | THE SECOND MEDIUM TERM PLAN FOR HEALTH
This document shall serve as the most comprehensive set of guidelines on the safe management of waste generated from heath care activities in the country. It incorporates the requirements of all Philippine laws and regulations governing HCWM and is designed for the use of individuals, public and pri...
The WHO South-East Asia (SEA) Region bears a high burden of tuberculosis (TB) and MDR-TB. In 2015, the Region accounted for nearly 200 000 or 35% of the global estimated new RR/MDR-TB cases eligible for treatment. Extensively drug-resistant TB (XDRTB) has also been reported from s...
Including Therapeutic Food, Dietary Vitamin and Mineral Supplementation - 2nd edition
A manual for developing national action plans.This manual for developing national action plans to address antimicrobial resistance has been developed at the request of the World Health Assembly to assist countries in the initial phase of developing new, or refining existing national action plans in ...
Antimicrobial resistance (AMR) is a major global public health concern and a food safety issue. When pathogens become resistant to antimicrobial agents they can pose a greater human health risk as a result of potential treatment failure, loss of treatment options and increased likelihood and severi...
This manual for developing national action plans to address antimicrobial resistance has been developed at the request of the World Health Assembly to assist countries in the initial phase of developing new, or refining existing national action plans in line with the
strategic objectives of the Glo...
Antibiotics have been a critical public health tool since the discovery of Penicillin in 1928, saving the lives of millions of people around the world. In developing country like ours, where the burden of treatable disease is very high and access to health facilities and laboratories is difficult, a...
Supply of essential medicines and health technologies (6 April 2020)
This paper is one of a set of technical guidance papers developed by the WHO Regional Office for Europe to provide practical information and resources for decision-makers on measures to strengthen the health system response to C...
